Transition Therapeutics' Alzheimer's drug gets FDA fast-track status
(Reuters) - Canadian biopharmaceutical company Transition Therapeutics said the U.S. Food and Drug Administration granted a fast-track status to its A...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/5WRZZkbfvUw/story01.htm
No comments:
Post a Comment